These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22847316)

  • 1. 1,5-Anhydroglucitol in diabetes mellitus.
    Kim WJ; Park CY
    Endocrine; 2013 Feb; 43(1):33-40. PubMed ID: 22847316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
    Kim MJ; Jung HS; Hwang-Bo Y; Cho SW; Jang HC; Kim SY; Park KS
    Acta Diabetol; 2013 Aug; 50(4):505-10. PubMed ID: 21688018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
    Bai Y; Yang R; Song Y; Wang Y
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):220-225. PubMed ID: 29270924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
    Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
    Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
    Dungan KM; Buse JB; Largay J; Kelly MM; Button EA; Kato S; Wittlin S
    Diabetes Care; 2006 Jun; 29(6):1214-9. PubMed ID: 16731998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-Anhydroglucitol and glycated albumin in glycemia.
    Koga M
    Adv Clin Chem; 2014; 64():269-301. PubMed ID: 24938022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of 1.5-anhydroglucitol for monitoring glycemic control in islet transplant recipients.
    Peixoto EM; Bozkurt NC; Messinger S; García MI; Lauriola V; Corrales A; Herrada E; Ricordi C; Alejandro R
    Cell Transplant; 2014; 23(10):1213-9. PubMed ID: 23803279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial glycemic control conditions in relation to urinary N-acetyl-β-D-glucosaminidase in patients with type 2 diabetes mellitus without low glomerular filtration rate.
    Ouchi M; Oba K; Motoyama M; Tsunoda M; Yamashita H; Aoyama J; Saigusa T; Ishii K; Yano H; Hashimoto M; Sekimizu K; Suzuki T; Nakano H
    Diabetes Technol Ther; 2014 Jan; 16(1):41-7. PubMed ID: 24111861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Dungan KM
    Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic variability and diabetes retinopathy: a missing link.
    Hsu CR; Chen YT; Sheu WH
    J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,5-anhydro-D-glucitol: a novel marker of glucose excursions.
    Dworacka M; Winiarska H; Szymanska M; Kuczynski S; Szczawinska K; Wierusz-Wysocka B
    Int J Clin Pract Suppl; 2002 Jul; (129):40-4. PubMed ID: 12166605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus.
    Nguyen TM; Rodriguez LM; Mason KJ; Heptulla RA
    Pediatr Diabetes; 2007 Aug; 8(4):214-9. PubMed ID: 17659063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 1,5-anhydroglucitol levels in patients with fulminant type 1 diabetes are lower than those in patients with type 2 diabetes.
    Koga M; Murai J; Saito H; Mukai M; Kasayama S; Imagawa A; Hanafusa T
    Clin Biochem; 2010 Oct; 43(15):1265-7. PubMed ID: 20709052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
    Yamanouchi T; Moromizato H; Shinohara T; Minoda S; Miyashita H; Akaoka I
    Metabolism; 1992 Aug; 41(8):862-7. PubMed ID: 1640864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES.
    Wright LA; Hirsch IB; Gooley TA; Brown Z
    Endocr Pract; 2015 Jul; 21(7):725-33. PubMed ID: 25786553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk.
    Gerich JE
    Diabetes Educ; 2006; 32(4):513-4, 520-2. PubMed ID: 16873589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified diabetes management: lessons from the diabetes control and complications trial.
    Mazze RS; Bergenstal R; Ginsberg B
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):43-51. PubMed ID: 7711992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects.
    Januszewski AS; Karschimkus C; Davis KE; O'Neal D; Ward G; Jenkins AJ
    Diabetes Res Clin Pract; 2012 Jan; 95(1):e17-9. PubMed ID: 22024285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls.
    Mehta SN; Schwartz N; Wood JR; Svoren BM; Laffel LM
    Pediatr Diabetes; 2012 May; 13(3):278-84. PubMed ID: 22060802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.
    Beisswenger PJ; Howell SK; O'Dell RM; Wood ME; Touchette AD; Szwergold BS
    Diabetes Care; 2001 Apr; 24(4):726-32. PubMed ID: 11315838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.